The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Medical Management of Advanced Heart Failure
Abstract
CONTEXT: Advanced heart failure, defined as persistence of limiting symptoms despite therapy with agents of proven efficacy, accounts for the majority of morbidity and mortality in heart failure. OBJECTIVE: To review current medical therapy for advanced heart failure. DATA SOURCES: We searched MEDLINE for all articles containing the term advanced heart failure that were published between 1980 and 2001; EMBASE was searched from 1987-1999, Best Evidence from 1991-1998, and Evidence-Based Medicine from 1995-1999. The Cochrane Library also was searched for critical reviews and meta-analyses of congestive heart failure. STUDY SELECTION: Randomized controlled trials of therapy for 150 patients or more were included if advanced heart failure was represented. Other common clinical situations were addressed from smaller trials as available, trials of milder heart failure, consensus guidelines, and both published and personal clinical experience. DATA EXTRACTION: Data quality was determined by publication in peer-reviewed literature or inclusion in professional society guidelines. DATA SYNTHESIS: A primary focus for care of advanced heart failure is ongoing identification and treatment of the elevated filling pressures that cause disabling symptoms. While angiotensin-converting enzyme inhibitors and beta-adrenergic agents can slow disease progression and prolong survival, titration and tolerability often present challenges. Most patients are not eligible for surgical intervention but do benefit from a medical regimen tailored to individual clinical and hemodynamic profiles and from heart failure management programs that reduce rehospitalization. Survival ranges from 80% at 2 years for patients rendered free of congestion to less than 50% at 6 months for patients with refractory symptoms, in whom end-of-life options may include hospice care and inactivation of implantable defibrillators. CONCLUSIONS: Current management of advanced heart failure is based more on consensus than on randomized trials. Systematic investigation should address not only new therapies but also strategies for selecting and optimizing therapies already available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Rose, E. A., Gelijns, A. C., Moskowitz, A. J., Heitjan, D. F., Stevenson, L. W., Dembitsky, W., Long, J. W., Ascheim, D. D., Tierney, A. R., Levitan, R. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa012175 · Cited by 3,977
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833 · cited 1×
“For class III to IV heart failure, hydralazine-nitrate therapy has shown the same effect on heart failure end points as ACE inhibitors although ACE inhibitors reduced deaths occurring unexpectedly.(55,56) Once a patient is stabilized and has been released from the hospital, ACE inhibitor doses can be increased as tole…”
BackgroundCazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., Garrigue, S., Kappenberger, L., Haywood, G. A., Santini, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441202 · Cited by 2,751
Rich, M. W., Beckham, V., Wittenberg, C., Leven, C. L., Freedland, K. E., & Carney, R. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331806 · Cited by 2,328
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01683-7 · Cited by 1,912
Mancini, D. M., Eisen, H., Kussmaul, W., Mull, R., Edmunds, L. H., & Wilson, J. R. (1991) · Circulation · doi:10.1161/01.cir.83.3.778 · Cited by 1,882
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
Troughton, R. W., Frampton, C. M., Yandle, T. G., Espine, E. A., Nicholls, M. G., & Richards, A. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02060-2 · Cited by 1,376
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303
Packer, M., Poole-Wilson, P. A., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Rydén, L., Thygesen, K., & Uretsky, B. F. (1999) · Circulation · doi:10.1161/01.cir.100.23.2312 · Cited by 1,244
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart Failure
Stevenson, L. W. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420060100040 · Cited by 1,025
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D., Grancelli, H., Perrone, S., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 920
Colucci, W. S., Elkayam, U., Horton, D. P., Abraham, W. T., Bourge, R. C., Johnson, A. D., Wagoner, L. E., Givertz, M. M., Liang, C.-S., Neibaur, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430403 · Cited by 911
Dries, D. L., Exner, D. V., Domanski, M. J., Greenberg, B., & Stevenson, L. W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00608-7 · Cited by 879
Results of coronary artery surgery in patients with poor left ventricular function (CASS).
Alderman, E. L., Fisher, L. D., Litwin, P., Kaiser, G. C., Myers, W. O., Maynard, C., Levine, F., & Schloss, M. (1983) · Circulation · doi:10.1161/01.cir.68.4.785 · Cited by 804
Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800
Does Increased Access to Primary Care Reduce Hospital Readmissions?
Weinberger, M., Oddone, E. Z., & Henderson, W. G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342206 · Cited by 800
Bittner, V. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510140062030 · Cited by 711
Hambrecht, R. (2000) · JAMA · doi:10.1001/jama.283.23.3095 · Cited by 689
Di Salvo, T. G., Mathier, M., Semigran, M. J., & Dec, G. W. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00511-n · Cited by 685
Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy
Bolling, S. F., Pagani, F. D., Deeb, G. M., & Bach, D. S. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70282-x · Cited by 682
Cheng, V., Kazanagra, R., Garcia, A., Lenert, L., Krishnaswamy, P., Gardetto, N., Clopton, P., & Maisel, A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01157-8 · Cited by 668
Silverberg, D. S., Wexler, D., Sheps, D., Blum, M., Keren, G., Baruch, R., Schwartz, D., Yachnin, T., Steinbruch, S., Shapira, I., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01248-7 · Cited by 644
A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
Cohn, J. N., Goldstein, S. O., Greenberg, B. H., Lorell, B. H., Bourge, R. C., Jaski, B. E., Gottlieb, S. O., McGrew, F., DeMets, D. L., & White, B. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392503 · Cited by 613
A systematic review of randomized trials of disease management programs in heart failure
McAlister, F. A., Lawson, F. M. E., Teo, K. K., & Armstrong, P. W. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00743-9 · Cited by 584
(2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432019 · Cited by 526
Heart failure: Evaluation and care of patients with left ventricular systolic dysfunction
Konstam, M. A., Dracup, K., Baker, D. W., Bottorff, M. B., Brooks, N. H., Dacey, R. A., Dunbar, S. B., Jackson, A. B., Jessup, M., Johnson, J. C., et al. (1995) · Journal of Cardiac Failure · doi:10.1016/1071-9164(95)90021-7 · Cited by 473
Preferences for quality of life or survival expressed by patients with heart failure
Lewis, E. F., Johnson, P. A., Johnson, W., Collins, C., Griffin, L., & Stevenson, L. W. (2001) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(01)00298-4 · Cited by 433
Grady, K. L., Dracup, K., Kennedy, G., Moser, D. K., Piano, M., Stevenson, L. W., & Young, J. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2443 · Cited by 407
Krumholz, H. M., Chen, Y.-T., Vaccarino, V., Wang, Y., Radford, M. J., Bradford, W. D., & Horwitz, R. I. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00705-0 · Cited by 379
HLee, W., & MPacker (1986) · Circulation · Cited by 365
Stevenson, L. W., Tillisch, J. H., Hamilton, M., Luu, M., Chelimsky-Fallick, C., Moriguchi, J., Kobashigawa, J., & Walden, J. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91166-4 · Cited by 336
Tkacova, R., Rankin, F., Fitzgerald, F. S., Floras, J. S., & Bradley, T. D. (1998) · Circulation · doi:10.1161/01.cir.98.21.2269 · Cited by 334
Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure
Lucas, C., Johnson, W., Hamilton, M. A., Fonarow, G. C., Woo, M. A., Flavell, C. M., Creaser, J. A., & Stevenson, L. W. (2000) · American Heart Journal · doi:10.1067/mhj.2000.110933 · Cited by 329
Metra, M., Nardi, M., Giubbini, R., & Cas, L. D. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90174-0 · Cited by 320
Sudden death prevention in patients with advanced ventricular dysfunction.
Stevenson, W. G., Stevenson, L. W., Middlekauff, H. R., & Saxon, L. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2953 · Cited by 309
Butman, S. M., Ewy, G. A., Standen, J. R., Kern, K. B., & Hahn, E. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90405-p · Cited by 293
Dries, D. L., Sweitzer, N. K., Drazner, M. H., Stevenson, L. W., & Gersh, B. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01408-5 · Cited by 286
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure
Weinfeld, M. S., Chertow, G. M., & Stevenson, L. W. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70113-4 · Cited by 278
Krumholz, H. M., Phillips, R. S., Hamel, M. B., Teno, J. M., Bellamy, P., Broste, S. K., Califf, R. M., Vidaillet, H., Davis, R. B., Muhlbaier, L. H., et al. (1998) · Circulation · doi:10.1161/01.cir.98.7.648 · Cited by 261
Can the Clinical Examination Diagnose Left-Sided Heart Failure in Adults?
Badgett, R. G. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540450068038 · Cited by 248
Chronic heart failure and micronutrients
Witte, K. K. A., Clark, A. L., & Cleland, J. G. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01227-x · Cited by 239
Inotropic therapy for heart failure: An evidence-based approach
Felker, G. M., & O’Connor, C. M. (2001) · American Heart Journal · doi:10.1067/mhj.2001.117606 · Cited by 232
Steimle, A. E., Stevenson, L. W., Chelimsky-Fallick, C., Fonarow, G. C., Hamilton, M. A., Moriguchi, J. D., Kartashov, A., & Tillisch, J. H. (1997) · Circulation · doi:10.1161/01.cir.96.4.1165 · Cited by 230
Moderate Alcohol Consumption and Risk of Heart Failure Among Older Persons
Abramson, J. L. (2001) · JAMA · doi:10.1001/jama.285.15.1971 · Cited by 227
Drazner, M. H., Hamilton, M. A., Fonarow, G., Creaser, J., Flavell, C., & Warner Stevenson, L. (1999) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(99)00070-4 · Cited by 227
Improving survival for patients with advanced heart failure: A study of 737 consecutive patients
Stevenson, W. G., Stevenson, L. W., Middlekauff, H. R., Fonarow, G. C., Hamilton, M. A., Woo, M. A., Saxon, L. A., Natterson, P. D., Steimle, A., Walden, J. A., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00341-x · Cited by 222
Impact of left ventricular cavity size on survival in advanced heart failure
Lee, T. H., Hamilton, M. A., Stevenson, L. W., Moriguchi, J. D., Fqnarow, G. C., Child, J. S., Laks, H., & Walden, J. A. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90883-e · Cited by 215
Effect of a Heart Failure Program on Hospitalization Frequency and Exercise Tolerance
Hanumanthu, S., Butler, J., Chomsky, D., Davis, S., & Wilson, J. R. (1997) · Circulation · doi:10.1161/01.cir.96.9.2842 · Cited by 203
Carr, J. G., Stevenson, L. W., Walden, J. A., & Heber, D. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90256-7 · Cited by 202
Primary Prevention of Sudden Cardiac Death in Heart Failure: Will the Solution Be Shocking?
Uretsky, B. F., & Sheahan, R. G. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00361-6 · Cited by 198
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison
(1998) · European Heart Journal · doi:10.1053/euhj.1997.0839 · Cited by 184
Physical examination of venous pressure: A critical review
McGee, S. R. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70175-9 · Cited by 182
Fonarow, G. C., Chelimsky-Fallick, C., Stevenson, L. W., Luu, M., Hamilton, M. A., Moriguchi, J. D., Tillisch, J. H., Walden, J. A., & Albanese, E. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90529-v · Cited by 178
Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation.
Louie, H. W., Laks, H., Milgalter, E., Drinkwater, D. C., Hamilton, M. A., Rc, B., & Stevenson, L. W. (1991) · PubMed · Cited by 169
Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure.
Stevenson, L. W., & Tillisch, J. H. (1986) · Circulation · doi:10.1161/01.cir.74.6.1303 · Cited by 166
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE Multicenter Trial
Oliva, F., Latini, R., Politi, A., Staszewsky, L., Maggioni, A. P., Nicolis, E., & Mauri, F. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70108-0 · Cited by 158
Clinical definition and epidemiology of advanced heart failure
Adams, K. F., & Zannad, F. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70251-0 · Cited by 158
Skotzko, C. E., Krichten, C. M., Zietowski, G., Alves, L., Freudenberger, R. S., Robinson, S., Fisher, M. L., & Gottlieb, S. S. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.19222 · Cited by 157
Combined Oral Hydralazine-Nitrate Therapy in Left Ventricular Failure
Pierpont, G. L., Cohn, J. N., & Franciosa, J. A. (1978) · CHEST Journal · doi:10.1378/chest.73.1.8 · Cited by 140
Slatton, M. L., Irani, W. N., HALL, S. A., Marcoux, L., Page, R. L., Grayburn, P. A., & Eichhorn, E. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00057-0 · Cited by 133
Metoprolol controlled release/extended release in patients with severe heart failure
Goldstein, S., Fagerberg, B., Hjalmarson, Å. C., KJEKSHUS, J. K., Waagstein, F., Wedel, H., & Wikstrand, J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01516-9 · Cited by 132
Left ventricular dysfunction--bedside Valsalva manoeuvre.
Zema, M. J., Restivo, B., Sos, T. A., Sniderman, K. W., & Kline, S. (1980) · Heart · doi:10.1136/hrt.44.5.560 · Cited by 115
Optimizing therapy for complex or refractory heart failure: A management algorithm
Stevenson, L. W., Massie, B. M., & Francis, G. S. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70257-1 · Cited by 107
Azevedo, E. R., Newton, G. E., Floras, J. S., & Parker, J. D. (2000) · Circulation · doi:10.1161/01.cir.101.17.2053 · Cited by 106
Massie, B. M., Berk, M. R., Brozena, S. C., Elkayam, U., Plehn, J. F., Kukin, M. L., Packer, M., Murphy, B. E., Neuberg, G. W., & Steingart, R. M. (1993) · Circulation · doi:10.1161/01.cir.88.2.492 · Cited by 102
Pardaens, K., Cleemput, J. V., Vanhaecke, J., & Fagard, R. H. (1997) · Heart · doi:10.1136/hrt.78.6.564 · Cited by 101
Sindone, A. P., KEOGH, A. M., Macdonald, P. S., McCosker, C., & Kaan, A. M. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)80012-9 · Cited by 80
Poole-Wilson, P. A. (1998) · Cited by 77
Twidale, N., MCDONALD, T., Nave, K., & Seal, A. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00119.x · Cited by 75
Disease management interventions to improve outcomes in congestive heart failure.
Roglieri, J. L., Futterman, R., McDonough, K. L., Malya, G., Karwath, K. R., Bowman, D., Skelly, J., & Warburton, S. W. (1997) · PubMed · Cited by 73
Target Heart Failure Populations for Newer Therapies
Stevenson, L. W., Couper, G., Natterson-Horowitz, B., Fonarow, G. C., Hamilton, M. A., Woo, M. A., & Creaser, J. W. (1995) · Circulation · doi:10.1161/01.cir.92.9.174 · Cited by 71
Low-dose amiodarone for atrial fibrillation
Middlekauff, H. R., Wiener, I., & Stevenson, W. G. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90967-h · Cited by 71
Effects of Pimobendan on Exercise Tolerance and Quality of Life in Patients with Heart Failure
Kubo, S. H. (2008) · Cardiology · doi:10.1159/000177481 · Cited by 50
Outpatient dobutamine for refractory congestive heart failure: advantages, techniques, and results.
Miller, L. W. (1991) · PubMed · Cited by 38
Schleman, K. A., Lindenfeld, J. A., Lowes, B. D., Bristow, M. R., Ferguson, D. A., Wolfel, E. E., Abraham, W. T., & Zisman, L. S. (2001) · Journal of Cardiac Failure · doi:10.1054/jcaf.2001.22491 · Cited by 28
Rites and Responsibility for Resuscitation in Heart Failure
Stevenson, L. W. (1998) · Circulation · doi:10.1161/01.cir.98.7.619 · Cited by 26
Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure
Binkley, P. F., Starling, R. C., Hammer, D. F., et al. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90507-h · Cited by 21
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
ATS/ACCP statement on cardiopulmonary exercise testing
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.2.211 · Cited by 3,026
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
ATS/ACCP statement on cardiopulmonary exercise testing
Ross, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.167.10.950 · Cited by 2,073
Metadata
- Authors
- Nohria, A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-02-06
- Volume
- 287
- Issue
- 5
- Pages
- 628
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2001485903
- Cited by
- 465
- References
- 85
- FWCI
- 20.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.